Telemedicine and Compounding Pharmacy · United States

Gimme Care

Gimme Care is a telemedicine platform offering weight loss programs with compounded GLP-1 medications, no insurance required, with free shipping and care from licensed US providers.

About Gimme Care

Gimme Care: telemedicine for compounded GLP-1 treatments

Gimme Care is an online healthcare platform operated by Start Gimme, LLC, focused on weight loss programs and longevity treatments with compounded medications. The company presents itself as a service that combines prescribing by licensed US providers with direct-to-home shipping, with no need for insurance and no pharmacy visits.

Care model and coverage

The service is available in all 50 states and the District of Columbia. Care begins with an online questionnaire that a licensed provider reviews to determine eligibility. In most states, treatment can begin without a video call, although in Kansas, Louisiana, Mississippi, New Mexico, and West Virginia a brief video or audio consultation is required before starting. Users have access to unlimited messaging with their provider, weight tracking, refill management, and shipment updates through an online portal. Refills are shipped every 28 days after a brief review, with discreet, free delivery.

Treatment catalog and pricing

The catalog includes weight loss and anti-aging treatments. Published prices are per month and vary by billing plan:

  • Compounded tirzepatide: $199 per month on the monthly plan; $163 per month on the 3-month plan.
  • Compounded semaglutide: $160 per month on the monthly plan; $130 per month on the 3-month plan.
  • Sermorelin Injection: $189 per month on the monthly plan; $179 per month on the 3-month plan.
  • NAD+ Injection: $129 per month on the monthly plan; $99 per month on the 3-month plan.
  • Cyanocobalamin (B12): $84 per month on the monthly plan; $66 per month on the 3-month plan.
  • MIC+B12: $129 per month on the monthly plan; $99 per month on the 3-month plan.
  • Glutathione Injection: $99 per month on the monthly plan; $63 per month on the 3-month plan.
  • NAD+ & Glutathione Bundle: available in the catalog.

The company states that the price includes medication, medical care, support, shipping, and supplies, with no hidden fees or memberships. It also offers ondansetron, according to the treatment list.

Providers and pharmacies

The medications are prepared by licensed compounding pharmacies in the United States. The company clarifies that these products are not FDA-approved or evaluated for safety, efficacy, or quality, and that they do not replace approved medications such as Mounjaro, Zepbound, Wegovy, or Ozempic. A prescription is required and treatments must be used under the supervision of a healthcare professional. The company notes that they are not approved for cosmetic weight loss.

Origin and team

Gimme Care was founded by Ari Feinberg, who previously launched a mobile IV drip clinic in Miami Beach. That experience led him to create a platform that seeks to simplify access to healthcare by combining technology, convenience, and relationships with industry professionals. Feinberg is the founder and CEO of the company.

Treatment considerations

The company warns that most patients tolerate semaglutide well, but side effects may occur, especially when starting or increasing the dose. Among the most common, which usually improve over time, it mentions nausea, vomiting, diarrhea, constipation, abdominal pain or bloating, burping, headache, fatigue, and reflux or indigestion. Less frequently, dizziness and injection site irritation are reported. It recommends smaller meals, avoiding fatty or spicy foods, increasing fluid intake, and not increasing the dose while symptoms persist. Providers can adjust the dose based on medical history and response to treatment. The company states that most patients benefit from long-term use and that, upon discontinuation, appetite and food triggers may return, so it recommends consulting before modifying treatment.

In brief

Telemedicine for weight loss with compounded GLP-1 medications